Skip to content

A comparative clinical study of Chandanadi vati and Bala tail matra basti to manage excessive bleeding per vaginum

A Comparative Clinical Study To Evaluate the Efficacy of Chandanadi vati And Bala Tail Matra Basti in the Management of Asrigdara W.S.R To Menorrahgia - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090611
Enrollment
40
Registered
2025-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Sponsors

State Ayurvedic College And Hospital Tulsidas Marg Turiyaganj Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having excessive, prolonged and intermenstrul bleeding. 2.Patient with age group of 20-45 years. 3.Patient Hb % more than 10 gm

Exclusion criteria

Exclusion criteria: 1.Patient having uterine fibroid, uterine polyps, adenomyosis. 2.Malignant growth in uterus. 3.Patients considered having thyroid dysfunction, liver dysfunction, coagulation disorders etc. 4.Patient having systemic illness like diabetes, and hypertension etc. 5.Patient with IUCD and OCP. 6.Patient giving history of recent delivery or abortion.

Design outcomes

Primary

MeasureTime frame
1.To evaluate the efficacy of Chandanadi Vati with Bala Tail matra basti in the management of Asrigdara w.s.r. To Menorrahgia. 2.To Compare the clinical efficacy of Chandanadi vati and Bala tail Matra basti in the management of Asrigdara w.s.r To Menorrhagia.Timepoint: 1.at 4 weeks 2.at 4 weeks

Secondary

MeasureTime frame
1.To study the critical review of ayurvedic & modern literature on Asrigdara w.s.r. To Menorrhagia. 2.To study the adverse effects of both the trial drug and procedure. 3. To find out safe, effective therapy that covers various clinical conditions of Asrigdara. 4.Reduction in pain,Duration,and amount of menstrual bleeding.Timepoint: after 30days after 30days after 30days of trial

Countries

India

Contacts

Public ContactDr Sima Bharti

State Ayurvedic College And Hospital Tulsidas marg Turiyaganj Lucknow

shashi.chd98@gmail.com8795545443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026